Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-23-010395

Options or other derivatives

  • Director acquired 2,053 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ferrante Karen Jean Director 2023-04-03 Grant or award · Stock Option (Right to Buy) +2,053 2,053 D: show line 1 in the form
Loading xslF345X04/doc4.xml…